Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1971 3
1972 4
1973 2
1974 6
1975 2
1976 2
1977 1
1978 5
1979 3
1980 1
1981 1
1982 6
1983 5
1984 1
1985 2
1986 4
1987 1
1988 1
1990 2
1991 1
1992 3
1993 1
1995 2
1996 1
1997 2
1998 3
1999 7
2000 2
2001 5
2002 3
2003 16
2004 6
2005 13
2006 8
2007 16
2008 14
2009 26
2010 22
2011 18
2012 17
2013 24
2014 14
2015 19
2016 33
2017 21
2018 23
2019 25
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

358 results
Results by year
Filters applied: . Clear all
Page 1
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
Hohenberger M, Cardwell LA, Oussedik E, Feldman SR. Hohenberger M, et al. J Dermatolog Treat. 2018 Feb;29(1):13-18. doi: 10.1080/09546634.2017.1329511. Epub 2017 May 31. J Dermatolog Treat. 2018. PMID: 28521565 Review.
Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease.
Deepak P, Sandborn WJ. Deepak P, et al. Gastroenterol Clin North Am. 2017 Sep;46(3):603-626. doi: 10.1016/j.gtc.2017.05.013. Gastroenterol Clin North Am. 2017. PMID: 28838418 Review.
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP. Burmester GR, et al. Ann Rheum Dis. 2013 Apr;72(4):517-24. doi: 10.1136/annrheumdis-2011-201244. Epub 2012 May 5. Ann Rheum Dis. 2013. PMID: 22562972 Free PMC article. Review.
Anti-TNF Therapy.
Udalova I, Monaco C, Nanchahal J, Feldmann M. Udalova I, et al. Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.MCHD-0022-2015. Microbiol Spectr. 2016. PMID: 27726761 Review.
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease.
Horneff G, Seyger MMB, Arikan D, Kalabic J, Anderson JK, Lazar A, Williams DA, Wang C, Tarzynski-Potempa R, Hyams JS. Horneff G, et al. J Pediatr. 2018 Oct;201:166-175.e3. doi: 10.1016/j.jpeds.2018.05.042. Epub 2018 Jul 25. J Pediatr. 2018. PMID: 30054164 Free article. Clinical Trial.
Risankizumab: First Global Approval.
McKeage K, Duggan S. McKeage K, et al. Drugs. 2019 Jun;79(8):893-900. doi: 10.1007/s40265-019-01136-7. Drugs. 2019. PMID: 31098898 Review.
Connections between psoriasis and Crohn's disease.
Najarian DJ, Gottlieb AB. Najarian DJ, et al. J Am Acad Dermatol. 2003 Jun;48(6):805-21; quiz 822-4. doi: 10.1067/mjd.2003.540. J Am Acad Dermatol. 2003. PMID: 12789169 Review.
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T. Schreiber S, et al. Ann Rheum Dis. 2019 Apr;78(4):473-479. doi: 10.1136/annrheumdis-2018-214273. Epub 2019 Jan 23. Ann Rheum Dis. 2019. PMID: 30674475 Free PMC article.
358 results
Jump to page
Feedback